Beijer Discussion Paper 277: Financial dimensions of global zoonotic disease risks

Emerging and re-emerging infectious diseases with pandemic potential (EID) such as COVID-19 and avian influenza, pose serious threats to human health and wellbeing all over the world. The emergence and re-emergence of zoonotic diseases are affected by a number of interacting social, environmental and ecological changes. The financial sector plays an important, yet often ignored role as owners and investors in industries linked to anthropogenic changes in ecosystems associated with increased zoonotic disease risks. This discussion paper explores the connections between financial institutions, their investments through equity, and increased zoonotic disease risks in nine selected regional case studies in the world. Our analysis includes 54 companies operating in sectors associated with EID risks in the selected regions, with over 3,290 associated Global Universal Owners. Our results shows that U.S. based asset managers (Vanguard, State Street, BlackRock and T. Rowe Price) are the largest owners in terms of total equity size with ownership volumes ranging from $0,5 to $2 billion USD. The specific patterns of cross-national ownership however, depend on the case study region of interest, thus making not only global but also regional investors central. Our network analysis of company and investor headquarters show that the governments of Norway and France are particularly influential. North America, and European countries together with China, Australia, Argentina and Brazil form the largest community in the global investor and corporate network. 

Read article

Citation: Galaz. V., J. Rocha, P.A. Sanchez García, T. Roukny, P. Søgaard Jørgensen, A. Dauriach, and A. Golland. 2022. Beijer Discussion Paper Series.

Beijer Discussion Paper 277: Financial dimensions of global zoonotic disease risks

Beijer Discussion Paper 277: Financial dimensions of global zoonotic disease risks

Beijer Discussion Paper 277: Financial dimensions of global zoonotic disease risks

This website uses cookiesfor statistics and user experience.

This website uses cookies to improve your user experience, to provide a basis for improvement and further development of the website and to be able to direct more relevant offers to you.

Feel free to read ours privacy policy. If you agree to our use, choose Accept all. If you want to change your choice afterwards, you will find that option at the bottom of the page.

Cookies